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Abstract
Background: Although the precise mechanism of initial lesion development in multiple sclerosis (MS) remains
unclear, two different neuropathological findings have been reported as a potential early pathology of MS:
“microglial nodules” and “newly forming lesions”, both of which contain neither T cell infiltration nor demyelination.
In microglial nodules, damaged axons were associated with a small number of aggregated macrophages/microglia,
while oligodendrocyte apoptosis was a characteristic in newly forming lesions. However, is the presence of
“microglial nodules” and “oligodendrogliopathy” mutually exclusive? Might these two different observations be
the same neuropathology (as proposed by the concept, “preactive lesions”), but interpreted differently based on
the different theories of early MS lesion development, using different staining methods?
Discussion: Since two studies are looking at two distinct aspects of early MS pathogenesis (one focused on axons
and the other on oligodendrocytes), in a sense, one can say that these two studies are complementary. On the
other hand, experimentally, Wallerian degeneration (WD) has been demonstrated to induce both microglial nodules
and oligodendrocyte apoptosis in the central nervous system (CNS). Here, when encephalitogenic T cells are
present in the periphery in both autoimmune and viral models of MS, induction of WD in the CNS has been shown
to result in the recruitment of T cells along the degenerated tract, leading to demyelination (Inside-Out model).
These experimental findings are consistent with early MS pathology described by both “microglial nodules” and
“newly forming lesions”.
Conclusions: The differences between the two neuropathological findings may be based on the preference of
staining methods, where one group observed axonal and microglial pathology and the other observed
oligodendrocyte apoptosis; a Janus face that is looked at from the two different sides.
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Background
Although the precise mechanism of initial lesion devel-
opment in multiple sclerosis (MS) remains unclear, two
different neuropathological findings have been reported
as a potential early event of MS: “microglial nodules
(MGNs)” and “newly forming lesions (NFLs)” both of
which contain neither T cell infiltration nor demyelin-
ation [1, 2]. Singh et al. [1] described that damaged
axons were associated with a small number of aggre-
gated macrophages/microglia, i.e., MGNs, in the normal
appearing-white matter (NAWM) of MS. Microglia
expressed major histocompatibility complex (MHC)
class II molecules, while axons were immunoreactive to
antibodies against non-phosphorylated neurofilament
and neuropeptide Y receptor Y1, suggesting that these
axons are undergoing Wallerian degeneration (WD).
They also found that MGNs were not specific to MS,
but also in the affected adjacent NAWM after infarction
and traumatic brain injury, but not epilepsy. The authors
proposed that MGNs are an early event of MS and occur
as a reaction to WD, since the author group has
shown that there was no association with blood vessels,
blood-brain barrier (BBB) breakdown, or T cell infiltration
[1, 3]. The authors discussed how MGNs are different
from two other analogous MS lesions: 1) Pattern III le-
sions by Lucchinetti et al. [4] and 2) NFLs (or prephagocy-
tic areas) [2], since both of which contain oligodendrocyte
apoptosis and are described in terms of oligodendroglio-
pathy. NFLs have been proposed by Barnett et al. [2] as a
potential early MS lesion, which are composed of oligo-
dendrocyte apoptosis and microglial activation in NAWM
but little or no lymphocytes.
However, is the presence of “MGNs” and “oligoden-
drogliopathy” mutually exclusive? Might these two dif-
ferent observations be the same neuropathology, but
interpreted differently based on the different theories of
early MS lesion development, using different staining
methods? While MGNs seemed to be initiated by WD,
could it be accompanied by oligodendrocyte apoptosis?
To address these questions, we discussed that “MGNs”
are similar to findings in a viral model of MS, and com-
pared “MGNs” with other early MS lesions, “NFLs”.
Discussion
Interaction between axons and oligodendrocytes
Although WD has been demonstrated to induce oligo-
dendrocyte apoptosis along the degenerated tract, for
example, after spinal cord injury [5, 6], Singh et al. [1]
did not investigate whether oligodendrocyte apoptosis
was present in the NAWM. Since oligodendrocyte apop-
tosis can be induced by WD that disrupts the cross-talk
between axons and myelin [7], oligodendrocyte apop-
tosis can be not only seen in the oligodendrogliopathy
whose primary target is oligodendrocytes, but also
triggered by primary WD. Clinically and experimentally,
it has been shown that oligodendrocyte damage/survival
and axonal damage/preservation can influence each
other. Which comes first has to be interpreted with cau-
tion. It should be noted that neither Lucchinetti's pat-
tern criteria nor Barnett’s NFLs included a detailed
evaluation of axonal degeneration, while Barnett et al.
[2] described that “axonal changes in general were rela-
tively inconspicuous in NFLs of acute MS cases” (the
data were not shown). Here, if ‘relatively’ means that a
small number of damaged axons were present, their
NFLs are similar to MGNs, since microglial activation in
the absence of lymphocytes is another characteristic of
NFLs [8]. Interestingly, in NFLs, Barnett et al. [2] found
complement activation, which has also been demon-
strated along the tract of WD [9]; activated complement
components within these areas may recruit inflamma-
tory cells into the central nervous system (CNS).
Outside-In and Inside-Out models in MS
We have proposed two model theories of lesion develop-
ment in MS: the Outside-In model and the Inside-Out
model [5, 10]. In the Outside-In model, MS lesions
develop from the outside (myelin) to the inside (axons);
in the Inside-Out model, the lesions develop from the
inside (axons) to the outside (myelin) [11]. The Outside-
In model refers to a primary CNS demyelination, usually
induced by anti-myelin autoimmune cells generated in
the periphery, while the Inside-Out model refers to a
primary CNS axonal degeneration and subsequent re-
cruitment of systemic/adaptive immune cells. The target
of effector cells in an autoimmune model of MS, experi-
mental autoimmune encephalomyelitis (EAE), is a mye-
lin antigen; CNS damage in EAE is explained by the
Outside-In model. On the other hand, in a viral model
of MS, Theiler’s murine encephalomyelitis virus (TMEV)
infection, axonal degeneration precedes demyelination
[12, 13]; initial lesion development in TMEV-induced
demyelinating disease (TMEV-IDD) is explained by the
Inside-Out model.
TMEV-IDD (Inside-Out model) connects MGNs and NFLs
In TMEV infection, a small number of damaged axons
are detectable in the NAWM of the spinal cord in the
absence of demyelination, T cell infiltration, or viral anti-
gen as early as 1 week post infection (p.i.) [10]. Two to
three weeks p.i., MGNs are observed along with an in-
creased number of damaged axons in the NAWM
(Fig. 1), where activated microglia change from dendritic
morphology to more rounded phagocytes, indicating
that damaged axons are being phagocytosed. Apoptosis
of uninfected oligodendrocytes is also detectable in the
NAWM of the spinal cord at this early stage [12], while
T cell infiltration and demyelination become obvious
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after 4 weeks p.i. (chronic stage). The viral antigen is
seen in neurons of the gray matter of the brain dur-
ing the early stage, but in macrophages and glial cells
of the white matter of the spinal cord during the
chronic stage [10]. Thus, during the early stage of
TMEV infection, MGNs, axonal degeneration, and
oligodendrocyte apoptosis are present in the NAWM
of the spinal cord, which precedes demyelination and
T cell infiltration. This pathology is similar to the
findings regarding early MS lesions described by both
the Singh and the Barnett groups. Interestingly, one
of the characteristics of TMEV-IDD is vacuolar de-
myelination, in which lesions appear vacuolar because
of axonal swelling. Although Barnett et al. [2] also
described that the NFLs appeared “vacuolar”, the
authors speculated that the cause of the vacuolated
tissue was because of the presence of widespread
intramyelinic edema.
Fig. 1 Early lesion development theories of multiple sclerosis (MS) and its viral model. When axonal injury (arrow) occurs in Neuron A, it causes
degeneration of the distal part of transected axons [Wallerian degeneration (WD)]. This leads to activation of microglia [microglial nodules (MGNs)]
and oligodendrocyte apoptosis along the degenerated axon of Neuron A’, which is followed by demyelination of the nerve fiber of Neuron A”. Here,
the lesion develops from the inside axon to the outside myelin (Inside-Out model). Later, the changes in the microenvironment of Neuron A” recruit
encephalitogenic T cells from the systemic circulation to the site of WD, where extravasated T cells from the blood vessels attack myelin sheaths
of neighboring Neurons B and C, resulting in demyelination. Apoptotic oligodendrocytes that make myelin sheaths of Neuron A” also result in
demyelination of Neurons C and D. In this active MS plaque, demyelination of Neurons B, C, and D can occur without the damage of axons (primary
demyelination, Outside-In model). In a viral model of MS, Theiler’s murine encephalomyelitis virus (TMEV) infection, axonal degeneration, MGNs, and
oligodendrocyte apoptosis are visualized by non-phosphorylated neurofilament staining, lectin cytochemistry [Ricinus communis agglutinin (RCA) I],
and the terminal deoxynucleotidyl-transferase-mediated dUTP-biotin nick-end labeling (TUNEL) method, respectively, during the early stage of TMEV
infection, 1–2 weeks post infection (p.i.), in the normal appearing white matter, preceding demyelination. Full-blown demyelination and
T cell infiltration are visualized by Luxol fast blue staining and anti-CD3 immunohistochemistry during the chronic stage of TMEV infection
more than 1 month p.i, which is called TMEV-induced demyelinating disease (TMEV-IDD)
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Induction of MHC class II molecules in microglial ac-
tivation (i.e., MGNs) along the tract of WD was first
demonstrated experimentally by Konno et al. [14]. Then,
encephalitogenic T cells were adoptively transferred to
induce passive EAE in rats, in which MHC class II mole-
cules had been induced on microglia at the sites of WD
without BBB breakdown. The recipient rats developed
distinct inflammatory lesions that corresponded with the
distribution of activated microglia; e.g., in the ipsilateral
thalamus after cortical cryoinjury [15]. Here, axonal
degeneration in the presence of MGNs recruited en-
cephalitogenic T cells from the periphery to the sites of
WD. We confirmed this in TMEV-IDD [16]. We in-
duced WD without BBB breakdown in the one side of
the dorsal funiculus of the spinal cord by killing dorsal
root ganglion (DRG) cells by toxic lectin injection into
the one side of sciatic nerve. Lectin injection alone in-
duced WD with MGNs in the ipsilateral half of the dor-
sal funiculus with no inflammatory demyelination. If the
same procedure was conducted in TMEV-infected mice,
T cell infiltration and demyelination were induced along
the sites of the WD. Since the dorsal funiculus is spared
in control mice with TMEV-IDD, experimentally-
induced WD with MGNs likely recruited T cells to the
sites of WD. These findings showed that 1) WD alone is
enough to induce MGNs (but not demyelination), 2) it
can also recruit encephalitogenic T cells, only if these T
cells are present in the periphery, and 3) these T cells
are required for full blown demyelination. This may ex-
plain why there have been only anecdotal reports that
CNS neurotrauma was associated with the onset of MS;
for recruitment of T cells into the CNS, the presence of
activated T cells in the periphery that have a potential to
home CNS is required (such as T cells specific for CNS
antigens or T cells specific for viruses that persistently
infect the CNS).
The term, “preactive lesions (PALs)”, includes MGNs, NFLs,
and other early MS lesion concepts
As we discussed above, experimentally, the lesions with
histological features of both MGNs and NFLs can be
reproduced in animal models of MS. In human MS,
Amor and her collaborating groups (e.g., van der Valk
and van Noort) have used the term, “preactive lesions
(PALs)”, which link seemingly unrelated findings and
theories of early MS lesions, based on by their own find-
ings as well as neuropathology and neuroimaging find-
ings by others [17–20]. The concept “PALs” includes
MGNs, NFLs, Pattern III MS lesions, and other early
MS lesions, based on the common pathological findings:
microglial activation in the apparent absence of infiltrat-
ing leukocytes before any signs of apparent demyelin-
ation. In “PALs”, activated microglia co-clustered with
apoptotic oligodendrocytes and/or oligodendrocytes
expressing anti-apoptotic molecules, suggesting that
oligodendrocyte stress may trigger microglial activations.
Other possible triggers for microglial activation in PALs
include axonal degeneration and infections [17, 19];
induction of pattern recognition receptors, such as toll-
like receptors (TLRs), has been shown in PALs [21, 22].
Neuroimaging studies of NAWM are consistent with the
concept of PALs [17].
While the current concept of “PALs” seems to reason-
ably unify most early MS lesion concepts, there have
been changes in the usages of terminology of early MS
lesions (depending on the authors), which may hamper
neuropathologists’ ability to reach a consensus on early
MS lesion pathology. One issue is the presence of peri-
vascular lymphocyte infiltration. The current concepts of
PALs and MGNs as well as NFLs in the original article
agree that microglial activation occurs without perivas-
cular lymphocyte extravasation into CNS parenchyma in
early MS lesions. Confusingly, however, mild perivascu-
lar lymphocyte infiltration has been seen occasionally in
several pathology manuscripts on early MS lesions: for
example, 1) the first manuscripts that described “(p)re-
active lesion” by De Groot et al. [23] defined PALs as
“perivascular accumulation of lymphocytes in microves-
sels”, and 2) more recent manuscripts on “NFLs”
described mild T cell infiltration [24]. In addition, oligo-
dendrocyte apoptosis and axonal degeneration have been
rarely examined simultaneously, while the presence of
axonal degeneration in early MS lesions differed among
the reports: e.g. detected (or correlated) [1], not detected
(not correlated) [3], or not examined by most reports.
Remaining questions: 1) Transition from early MS lesions
to active MS plaques and 2) Role of astrocytes
PALs have been suggested not necessarily leading to
lymphocyte infiltration; PALs may not always develop
into inflammatory demyelinating lesions but can resolve
without subsequent disorder [19]. Although the precise
molecular mechanism that determines the development
from PALs to inflammatory demyelinating lesions is not
clear in MS or its animal models, it has been proposed
that production of anti-inflammatory cytokines, such as
interleukin (IL)-10, from microglia would lead to lesion
resolution. On the other hand, induction of pro-
inflammatory cytokines, such as tumor necrosis factor
(TNF)-α, from activated microglia likely activates endo-
thelial cells [18, 19], leading to upregulation of adhesion
molecules on endothelial cells, including vascular cell
adhesion molecule (VCAM)-1 and intracellular adhesion
molecule (ICAM)-1 [25]. Elucidation of these plausible
sequential changes in cytokine and adhesion molecule
profiles will lead to better understanding of a transition
from early MS lesions to active MS plaques.
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Lastly, although we discussed the involvement of three
major parenchymal cell types of the CNS, microglia,
neurons (axons), and oligodendrocytes, in early MS
lesions, the role of the forth major cell type, astrocytes,
remains unclear. Although only a few manuscripts
briefly described the absence of astrogilosis and a lack of
upregulation of MHC molecules on astrocytes in early
MS lesions [3, 17], quantitative and time course analyses
of astrocytes have not been a major focus of early MS
lesion studies both clinically and experimentally, includ-
ing the TMEV model. However, regardless of being acti-
vated or not, astrocytes could play a role in the early MS
lesions. For example, astrocytes are a component of neu-
rovascular and gliovascular units, interacting with blood
vessels, and regulating blood flow and BBB functions
[26]. Axonal damage, not only in the CNS but also per-
ipheral nerves (e.g., induced by peripheral nerve ligation
or toxin injection), has been shown to induce astrocyte
activation, while peripheral nerve injury can also activate
satellite glial cells in the dorsal root ganglion [27, 28].
Such activated astrocytes (and satellite glial cells) have
been shown to produce pro-inflammatory cytokines,
such as TNF-α and IL-1β, which can impair BBB
function [16, 26]. Thus, the changes in astrocytes are
worth examining together with microglia, axonal, and
oligodendrocyte pathology in early MS lesions and its
animal models.
Conclusions
WD has been shown to induce MGNs (microglial activa-
tion) and oligodendrocyte apoptosis. WD can result in
the recruitment of T cells along the degenerated tract,
leading to demyelination in both autoimmune and viral
models. These experimental findings are consistent with
early MS pathology described by both the Singh and the
Barnett groups, and support that MGNs and NFLs can
be an early MS lesion. The differences between the two
research groups may be based on their theories and
staining methods; a Janus face that is looked at from the
two different sides.
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